
Year
DEALS // DEV.
Country
Therapeutic Area
Study Phase
Deal Type
Product Type
Dosage Form
Lead Product
Target

Boost your online visibility by uploading your products, APIs, FDFs, intermediates, excipients, and services for free on PharmaCompass.
Rank higher among suppliers and expand your reach across the internet efficiently and cost-effectively.
Lead Product(s) : Prof-001
Therapeutic Area : Infections and Infectious Diseases
Study Phase : Phase II/ Phase III
Recipient : ProFem GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
Details : Prof-001 is a drug candidate, which is currently being evaluated in phase II/ phase III clinical studies for the treatment of Candidiasis, Vulvovaginal.
Product Name : Undisclosed
Product Type : Undisclosed
Upfront Cash : Inapplicable
February 02, 2021
Lead Product(s) : Prof-001
Therapeutic Area : Infections and Infectious Diseases
Highest Development Status : Phase II/ Phase III
Recipient : ProFem GmbH
Deal Size : Inapplicable
Deal Type : Inapplicable
